Cargando…
From SOMAmer-Based Biomarker Discovery to Diagnostic and Clinical Applications: A SOMAmer-Based, Streamlined Multiplex Proteomic Assay
Recently, we reported a SOMAmer-based, highly multiplexed assay for the purpose of biomarker identification. To enable seamless transition from highly multiplexed biomarker discovery assays to a format suitable and convenient for diagnostic and life-science applications, we developed a streamlined,...
Autores principales: | Kraemer, Stephan, Vaught, Jonathan D., Bock, Christopher, Gold, Larry, Katilius, Evaldas, Keeney, Tracy R., Kim, Nancy, Saccomano, Nicholas A., Wilcox, Sheri K., Zichi, Dom, Sanders, Glenn M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195687/ https://www.ncbi.nlm.nih.gov/pubmed/22022604 http://dx.doi.org/10.1371/journal.pone.0026332 |
Ejemplares similares
-
Measurement of Cetuximab and Panitumumab-Unbound Serum EGFR Extracellular Domain Using an Assay Based on Slow Off-Rate Modified Aptamer (SOMAmer) Reagents
por: Park, Noh Jin, et al.
Publicado: (2013) -
Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF
por: Ashley, Shanna L., et al.
Publicado: (2016) -
Slow Off-Rate Modified Aptamer (SOMAmer) Proteomic Analysis of Patient-Derived Malignant Glioma Identifies Distinct Cellular Proteomes
por: Thanasupawat, Thatchawan, et al.
Publicado: (2021) -
Aptamer-based multiplexed proteomic technology for biomarker discovery
por: Gold, Larry, et al.
Publicado: (2010) -
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
por: Gold, Larry, et al.
Publicado: (2010)